Institute of Immunology (4570) Earnings: Operating Income Surges 116.5% YoY to 117 Million Yen

The Institute of Immunology, Co., Ltd. (4570) released its latest financial results, reporting that operating income surged 116.5% year-on-year to 117 million yen. Net sales reached 286 million yen, representing a 35.2% increase compared to the same period of the previous year. Profitability improved dramatically, with ordinary income jumping 108.7% to 120 million yen, and net income attributable to owners of the parent growing 64.5% to 100 million yen.

From a financial perspective, the company maintains a robust foundation with an equity ratio of 84.8%. Retained earnings stand at 800 million yen against interest-bearing debt of 170 million yen, highlighting a stable balance sheet structure. Operating cash flow reached 300 million yen, free cash flow is 180 million yen, and cash and cash equivalents stand at 930 million yen, reflecting strong cash-generating capabilities and solid operational efficiency in the current period.